Articles tagged with Biotechnology
The symposium, The Architects of Aging, brings together leaders in biotechnology and biomedical research to target the underlying mechanisms of aging. Experts will present cutting-edge interventions that aim to modify biological processes of aging, with a focus on extending healthspan.
Researchers have discovered how Cpf1, a new molecular scissor, can act like a GPS to identify its destination in the genome, enabling precise genome modification and repair. The high precision of Cpf1 will improve the use of this technology in repairing genetic damage and other medical applications.
Research suggests that inferior synthetic horns can drive out wild horn suppliers through adverse selection, reducing poaching and driving down prices. Nonprofits could play a key role in producing these synthetic horns, promoting competition and increasing market supply.
Douglas Wallace receives the award for his pioneering work in mitochondrial genetics, leading to insights into human genealogy and implications for treating metabolic and degenerative diseases. The recognition acknowledges the crucial role of mitochondrial DNA genetics and bioenergetics in common disease etiology.
Professor Tyagi received the Outstanding Scientist Award from the International Bioprocessing Association for his outstanding contribution to environmental biotechnology. He has also earned numerous accolades, including awards from the American Academy of Environmental Engineers and Scientists.
Professor Sang Yup Lee was elected as a foreign associate to the US National Academy of Sciences (NAS) and previously to the US National Academy of Engineering (NAE). He is the first Korean to be elected to both prestigious academies, recognized for his leadership in microbial biotechnology and metabolic engineering.
The Moscow State University has opened a new cryobank to store biotechnological plant material, including rare species cell cultures. The facility aims to prevent cross-contamination by storing biological samples in nitrogen vapor, not liquid nitrogen.
A new study found that health insurance reimbursement for complementary healthcare services is significantly lower than for primary care physicians. The likelihood of reimbursement was 69% lower for acupuncturists, 71% lower for chiropractors, and 62% lower for doctors of naturopathic medicine.
Scientists discovered a caterpillar can break down polyethylene, a tough plastic found in shopping bags. The wax worm's saliva contains an enzyme that degrades the chemical bonds in the plastic, reducing its mass by 92mg after 12 hours.
Researchers have found a way for a caterpillar to break down polyethylene, a common type of plastic. The larvae of the Galleria mellonella moth can digest and chemically transform polyethylene into ethylene glycol, offering a potential solution to managing plastic waste.
The American Telemedicine Association has published new guidelines to improve remote stroke care using telemedicine communication technologies. The guidelines describe the network of audio-visual communication systems and computer systems needed to link an expert stroke team with a remote patient, aiming to rapidly diagnose and treat i...
A new study published in Nature Cell Biology reveals that the SHANK protein plays a crucial role in preventing the spread of breast cancer cells by regulating cell adhesion. The research also found that gene mutations in SHANK are linked to autism, demonstrating the protein's importance in both brain development and tumor invasion.
A study published in The Journal of Alternative and Complementary Medicine found that most healthcare providers and patients are unaware of the potential benefits and risks of consuming placenta after childbirth. Women who reported a history of mental health disorders were more likely to consider trying placentophagy.
Research and patents in biotechnology are increasing steadily across the developing world, with international collaborations playing a key role. The report highlights the growth of biotech papers from sub-Saharan Africa, particularly in infectious diseases research.
A survey of over 1600 biotechnology professionals predicts that the Trump presidency will negatively impact NIH research funding and STEM education. Foreign-born researchers educated in American universities are also expected to leave the country due to a perceived
Researchers propose using bacteria and archaea to monitor stored CO2 and convert it into useful products, such as ethanol and acetate. This approach could enable the detection of potential CO2 leaks and contribute to making large-scale capture and storage of CO2 feasible.
The article discusses patient and hernia-related factors that contribute to the success of laparoscopic ventral hernia repair. Relevant factors include obesity, smoking, diabetes, and cardiopulmonary disease, as well as hernia size, location, and recurrence.
A long-term follow-up study found significant improvement in health-related quality of life after bariatric surgery for patients with BPD-DS. The study evaluated 27 patients who underwent the procedure and compared their outcomes to pre-surgery scores and those from the general population.
Researchers have developed an innovative anti-biofilm coating with significant anti-adhesive potential, preventing destructive bacterial growth on metal surfaces. The coating has potential applications in medical implants, devices, and surgical equipment, as well as industrial uses such as preventing aquatic biofouling.
A biologically younger woman demonstrates the world's first successful gene therapy against human aging. Elizabeth Parrish's white blood cells showed a 20-year increase in telomere length, implying a reversal of age-related diseases.
The partnership will enable pharmaceutical companies to identify compounds most likely to succeed in human clinical trials, shortening the timeline to drug approval. Advanced lipidomic profiling analysis on tissues such as the liver will be made available, enhancing the depth and quality of scientific data.
Researchers developed a novel RNA-based hairpin molecule to inhibit microRNA activity in cells and mice. The plasmid-based microRNA inhibitor system effectively knocks down endogenous miRs, revealing roles for miRs in developmental pathways and cellular processes.
A Phase 2 study found that patients treated with MultiStem therapy experienced a complete or near full recovery from their stroke after one year, with 23.1% achieving this outcome compared to 8.2% of placebo patients. The therapy appears to reduce local inflammatory response and protect neurons in the brain.
Researchers developed a designer recombinase called Brec1 that can specifically remove the provirus from most primary HIV-1 isolates. The approach has shown promise as a potential new therapy for HIV, with antiviral effects without measurable cytotoxic or genotoxic side effects.
The special focus issue brings together experts from various fields to discuss the past, present, and future of nanomedicine. It addresses current debates and future perspectives on nanomedical research, including social, ethical, and safety aspects.
Recent genome engineering and gene editing breakthroughs will significantly impact biological system engineering, enabling more efficient production of drugs and other important products. Dr. Ryan Gill discusses the future directions and funding needs in the field.
Researchers can improve research and reduce costs by replacing animal-derived antibodies with modern technologies like recombinant antibodies and aptamers. This switch has the potential to save tens of thousands of animals from suffering in laboratories.
Biotech expert Mitchell Finer shares his experiences and strategies for achieving commercial success, including the importance of clinical data and access to capital. He also discusses the growth of companies like bluebird bio and Cell Genesys, and the potential for gene therapy to revolutionize treatment options.
Brazilian scientists review advances in nanodentistry, exploring how nanoparticles can improve dental materials, prevent oral diseases, and create wearable toothpaste. However, safety and cost concerns hinder the adoption of these new technologies.
A phase III clinical trial's results may lead to the first approved gene therapy product in the US for treating Leber congenital amaurosis type 2 (LCA2). The treatment, SPK-RPE65, could improve patients' ability to see and function at night or in dimmer light levels.
Researchers at Austrian Research Centre of Industrial Biotechnology (ACIB) have elucidated a new pathway that makes yeast Pichia pastoris unique. The study reveals the utilization of methanol as a nutrient, similar to plants using CO2, and demonstrates the leading role of Vienna researchers in biotech yeast research.
The company, Newcells Biotech Ltd, will use pioneering technology to create iPSCs for pharmaceutical, biotechnology, and academic customers, offering benefits in testing treatments on cells with specific genetic make-ups.
The 2015 BIO International Convention in Philadelphia featured the Innovation Zone, a 5,000-square-foot exhibit space dedicated to companies with cutting-edge biomedical technologies supported by NSF's Directorate for Engineering. The zone showcased over 75 companies, including those funded by the NSF Small Business Innovation Research...
Researchers at the University of Helsinki discovered that cytoplasmic intermediate filaments interact with specific contractile actin filament structures called arcs, which transport intermediate filaments towards the nucleus. Disruption of these interactions leads to defects in cell morphogenesis and shape abnormalities.
Researchers discovered a specific immune cell type that reduces inflammation and protects against liver damage. The Ly6C-negative monocyte subset dampens the immune response and induces anti-inflammatory genes in nearby cells.
Scientists at the University of Eastern Finland have identified two separate sites on the protein NOS1AP that can be blocked to reduce damaging signals caused by NOS-1 in brain cells. This breakthrough could lead to the development of new drugs for neurological diseases such as stroke, chronic pain, depression, and anxiety disorders.
Researchers have successfully introduced a gene into foetal cells from Luxi Yellow cattle to increase the levels of beneficial omega-3 oils in beef. The study found that introducing the fat1 gene resulted in over five times higher levels of these fatty acids.
Researchers at Stanford have created a new field of interactive biotechnology that allows users to interact with living cells using games and remote-controlled labs. The team developed three projects: arcade-style kiosks, biotic games for teaching bioengineering devices, and robotic biology cloud labs.
Self-affirmations help level the playing field, reducing power differences in high-stakes situations. Writing down a self-affirmation can be more effective than just thinking it, boosting confidence and performance.
The $2.5 million funding package supports five health innovations in India, including mobile daycare centers for migrant construction workers' children and early childhood development programs. Grand Challenges Canada has partnered with the Indian government to accelerate efforts to eliminate visceral leishmaniasis in Bihar.
Researchers at the University of Manchester have created a synthetic pathway for biosynthesis of renewable propane, paving the way for its commercial production. The breakthrough uses an engineered enzyme variant to redirect microbial pathways, producing propane as a clean-burning alternative to fossil fuels.
A special focus issue in Nanomedicine examines the intersection of nanomedicine and regenerative medicine, showcasing advancements in nanotopography, nanofunctionalization, and stem cell research. The field of nanoregeneration has grown exponentially over the last 15 years, with potential applications in drug discovery and cell targeting.
Researchers at ETH Zurich have developed a novel biotechnological solution to treat erectile dysfunction by triggering reliable erections with gene therapy and blue light exposure. The system works similarly across all mammals, including humans, and is expected to have few side effects.
The Austrian Centre of Industrial Biotechnology has developed the world's first continuous purification method for recombinant antibodies from clarified CHO cultures. This breakthrough technology is expected to significantly reduce production costs for highly valued drugs, such as cancer treatments and autoimmune disease therapies. The...
Continuous bioprocessing is gaining consideration as a method of industrial bioprocessing, with potential advantages including lower costs and increased efficiency. Dr. Konstantin Konstantinov and Dr. Charles Cooney emphasize the need for methods to evolve around this new platform.
Researchers at Helmholtz Center for Environmental Research have found that bioelectrochemical processes promise improved yields and can be economically competitive. The technology has the potential to save costs of up to 18% in EU and US markets, with estimated savings over a ten-year horizon reaching $50 million.
The National Collection of Yeast Cultures has added the 4,000th yeast strain to its collection, including a novel species found in Ecuador's Yasuní National Park. This discovery expands microbial biodiversity and offers new possibilities for sustainable biotechnology.
Scientists at TU Dresden have presented a novel method, real-time deformability cytometry (RT-DC), to mechanically screen large populations of cells quickly and accurately. This technology enables the continuous, on-the-fly mechanical screening of hundreds of cells per second.
A study reveals enzymatic hydrolysis and drying significantly alter lignocellulosic biomass nanostructure, reducing pore volume by up to 80%. The accessible reaction space is also reduced, hindering hydrolysis. This work sheds light on the importance of physical features in defining hydrolysis rates.
A new study published in Journal of Neurotrauma found that existing models for predicting outcomes after mild traumatic brain injury perform poorly. The study identified older age, pre-existing psychiatric conditions, and less education as the strongest predictors of poor outcomes after mTBI.
Researchers from CU School of Medicine and Taiga Biotechnologies have discovered a way to expand production of stem cells used to treat cancer patients. This breakthrough technology could also be used to treat inborn immunodeficiency conditions, metabolic diseases, and autoimmune disorders.
A new study reveals that better communication of basic research results during the discovery stage can lead to faster commercialization. Biotech firms often give up on inventions and transfer technology to other firms for repurposing in a new disease category, causing time losses earlier in the pathway.
The 2014 World Stem Cell Summit will bring together leading scientists, business leaders, and regulators to discuss the future of regenerative medicine. The summit will feature over 200 prominent speakers from more than 40 nations, exploring the latest scientific discoveries and innovative business models.
The Festschrift issue honors Dr. Koprowski's pioneering work on vaccines, including the oral polio vaccine, and its impact on cancer biology research. Dr. Koprowski's achievements have been recognized by CASIS, which enabled visionaries to explore life science research in microgravity environments.
Amunix is presenting unpublished data on its XTEN half-life extension technology, which extends the half-life of biologically active molecules via chemical conjugation. The technology has been used to extend the half-life of genetically fused therapeutic proteins and peptides.
Elsevier has launched an open-access journal, Computational and Structural Biotechnology Journal (CSBJ), on behalf of the Research Network of Computational and Structural Biotechnology. The journal publishes high-quality research articles and reviews in computational biotechnology, with a focus on mechanistic understanding through appl...
Scientists suggest that every town could have a small-scale cultured meat factory, producing sustainable and cruelty-free meat alternatives. The production process involves taking stem cells from cell banks and using them to create minced meat cakes.
Researchers are developing a new, freeze-stable tetanus vaccine using lipid nanoparticles and a hollow microneedle system. The delivery device can target specific areas of the skin, increasing vaccine efficacy.
A new paper from Rice University's Baker Institute calls for revised patenting guidelines to address the broad patent landscape in biotechnology. The authors suggest initial steps to reform patent licensing and require detailed patent descriptions to prevent costly lawsuits.
Researchers at Cedars-Sinai Medical Center will conduct a Phase II clinical trial to evaluate the safety and efficacy of 3K3A-APC, an experimental drug combining with rtPA to treat ischemic strokes. The study aims to reduce risks and improve outcomes for stroke patients.